Global Autoimmune Disease Testing Market Growth (Status and Outlook) 2025-2031

The global Autoimmune Disease Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Autoimmune Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Autoimmune Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Autoimmune Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Autoimmune Disease Testing players cover F.Hoffmann-La Roche Ltd, ZEus Scientific, Inc., Thermo Fisher Scientific Inc., QuestDiagnostics Incorporated, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Autoimmune Disease Testing Industry Forecast” looks at past sales and reviews total world Autoimmune Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Testing sales for 2025 through 2031. With Autoimmune Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Testing industry.

This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Autoimmune Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disease Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

Instrument

Reagent Consumables

Segmentation by Application:

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Scleroderma

Vasculitis

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

F.Hoffmann-La Roche Ltd

ZEus Scientific, Inc.

Thermo Fisher Scientific Inc.

QuestDiagnostics Incorporated

Abbott

Ql Diagnostics Inc

Werfen

Trinity Biotech

KsL Beutner Laboratories (Beutner)

Bio-Rad Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.